Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perla Lansang

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
British Journal of Clinical Pharmacology|August 11, 2021
Population pharmacokinetic and exposure-efficacy analysis of ixekizumab in paediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS)Kimberley Jackson, Laiyi Chua, Nieves Velez de Mendizabal, et al.
Journal of Cutaneous Medicine and Surgery|July 16, 2025
Navigating Bullous Pemphigoid: Consensus Recommendations for Diagnosis and Management-A Canadian PerspectiveFiona E Lovegrove, Maxwell B Sauder, Asfandyar Mufti, et al.
Dermatologic Therapy|August 21, 2022
Management of moderate-to-severe plaque psoriasis with biologics: A treat-to-target position paperJensen Yeung, Marc Bourcier, Melinda J Gooderham, et al.
Journal of the American Academy of Dermatology|June 1, 2019
Management of pediatric plaque psoriasis using biologicsPerla Lansang, James N Bergman, Loretta Fiorillo, et al.
Dermatology and Therapy|October 9, 2025
Considerations for Treating Generalized Pustular Psoriasis (GPP): A Narrative ReviewCharles W Lynde, Vimal H Prajapati, Melinda J Gooderham, et al.
Pediatric Dermatology|October 31, 2023
Multicenter Canadian case series of pediatric patients less than 12 years of age with moderate-to-severe atopic dermatitis treated with dupilumabSylvia Martinez-Cabriales, Danielle Marcoux, Carmen Liy-Wong, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 6, 2024
Considerations for defining and diagnosing generalized pustular psoriasisVimal H Prajapati, Charles W Lynde, Melinda J Gooderham, et al.
Dermatology and Therapy|July 17, 2025
Time to Onset of Action for Biologics and Targeted Treatments in Psoriasis: Systematic Targeted Literature Review and Network Meta-AnalysisKim A Papp, Ron Vender, Kerri Purdy, et al.
Journal of Cutaneous Medicine and Surgery|November 7, 2019
Approach to the Assessment and Management of Pediatric Patients With Atopic Dermatitis: A Consensus Document. Section IV: Consensus Statements on the Assessment and Management of Pediatric Atopic DermatitisPerla Lansang, Irene Lara-Corrales, James N Bergman, et al.
Dermatology and Therapy|September 12, 2021
Practical Management of Patients with Atopic Dermatitis on DupilumabKim A Papp, Chih-Ho Hong, M Perla Lansang, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
British Journal of Clinical Pharmacology|August 11, 2021
Population pharmacokinetic and exposure-efficacy analysis of ixekizumab in paediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS)Kimberley Jackson, Laiyi Chua, Nieves Velez de Mendizabal, et al.
Journal of Cutaneous Medicine and Surgery|July 16, 2025
Navigating Bullous Pemphigoid: Consensus Recommendations for Diagnosis and Management-A Canadian PerspectiveFiona E Lovegrove, Maxwell B Sauder, Asfandyar Mufti, et al.
Dermatologic Therapy|August 21, 2022
Management of moderate-to-severe plaque psoriasis with biologics: A treat-to-target position paperJensen Yeung, Marc Bourcier, Melinda J Gooderham, et al.
Journal of the American Academy of Dermatology|June 1, 2019
Management of pediatric plaque psoriasis using biologicsPerla Lansang, James N Bergman, Loretta Fiorillo, et al.
Dermatology and Therapy|October 9, 2025
Considerations for Treating Generalized Pustular Psoriasis (GPP): A Narrative ReviewCharles W Lynde, Vimal H Prajapati, Melinda J Gooderham, et al.
Pediatric Dermatology|October 31, 2023
Multicenter Canadian case series of pediatric patients less than 12 years of age with moderate-to-severe atopic dermatitis treated with dupilumabSylvia Martinez-Cabriales, Danielle Marcoux, Carmen Liy-Wong, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 6, 2024
Considerations for defining and diagnosing generalized pustular psoriasisVimal H Prajapati, Charles W Lynde, Melinda J Gooderham, et al.
Dermatology and Therapy|July 17, 2025
Time to Onset of Action for Biologics and Targeted Treatments in Psoriasis: Systematic Targeted Literature Review and Network Meta-AnalysisKim A Papp, Ron Vender, Kerri Purdy, et al.
Journal of Cutaneous Medicine and Surgery|November 7, 2019
Approach to the Assessment and Management of Pediatric Patients With Atopic Dermatitis: A Consensus Document. Section IV: Consensus Statements on the Assessment and Management of Pediatric Atopic DermatitisPerla Lansang, Irene Lara-Corrales, James N Bergman, et al.
Dermatology and Therapy|September 12, 2021
Practical Management of Patients with Atopic Dermatitis on DupilumabKim A Papp, Chih-Ho Hong, M Perla Lansang, et al.
Pageof 4